Evaluation of alternative strategies for optimizing glycemia: progress to date
- 1 October 2002
- journal article
- conference paper
- Published by Elsevier in The American Journal of Medicine
- Vol. 113 (6) , 23-35
- https://doi.org/10.1016/s0002-9343(02)01278-0
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- The importance of the β-cell in the pathogenesis of type 2 diabetes mellitusThe American Journal of Medicine, 2000
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusJournal of Clinical Investigation, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- UKPDS 26: sulphonylurea failure in non‐insulin‐dependent diabetic patients over six yearsDiabetic Medicine, 1998
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995
- Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic FunctionDiabetes, 1993
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes MellitusDiabetes, 1985
- Insulin Therapy in Obese, Non-insulin-dependent Diabetes Induces Improvements in Insulin Action and Secretion that Are Maintained for Two Weeks After Insulin WithdrawalDiabetes, 1984
- Insulin Treatment Reverses the Insulin Resistance of Type II Diabetes MellitusDiabetes Care, 1982